Bacillus Coagulans

Qanacsan

• Suurtagal inay wax ku ool u tahay ...
• Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...
• Taxaddarrada gaarka ah & digniinta:

Bacillus coagulans waa nooc ka mid ah bakteeriyada. Waxaa loo isticmaalaa si la mid ah lactobacillus iyo probiotics kale oo ah bakteeriya "faa'iido leh".

Dadku waxay u qaataan Bacillus coagulans xanuunka xannuunka mindhicirka (IBS), shuban, gaas, infekshinka hawo mareenka, iyo xaalado kale oo badan, laakiin ma jiraan caddeyn cilmi ah oo wanaagsan oo lagu taageerayo adeegsigaas.

Bacillus coagulans wuxuu soo saaraa aashitada loo yaqaan 'lactic acid' waxaana badanaa loo qaadaa inuu yahay lactobacillus. Xaqiiqdii, qaar ka mid ah badeecadaha ganacsiga ee ay ku jiraan Bacillus coagulans ayaa loo suuqgeeyaa sida “Lactobacillus sporogenes”. Si ka duwan bakteeriyada lactic acid sida lactobacillus ama bifidobacteria, Bacillus coagulans ayaa sameeya fallaadho. Spores waa cunsur muhiim u ah u sheegida Bacillus coagulans marka laga reebo bakteeriyada kale ee lactic acid.

Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran waxay qiimeysaa waxtarka ku saleysan caddeynta sayniska iyadoo loo eegayo cabirka soo socda: Wax ku ool ah, Suurta gal ah inuu wax ku ool yahay, suurtagal tahay wax ku ool ah, macquul ahaan waxtar la'aan, suurtagal ahaan waxtar la'aan, waxtar la'aan, iyo caddayn ku filan oo lagu qiimeeyo.

Qiimeynta waxtarka ee BACILLUS COAGULANS waa sida soo socota:

Suurtagal inay wax ku ool u tahay ...

• Cilad muddo-dheer ah ee mindhicirada waaweyn ee sababa calool xanuun (cillad maskaxeed xanaaqsan ama IBS). Daraasad caafimaad ayaa muujisay qaadashada Bacillus coagulans maalin kasta 56-90 maalmood waxay hagaajineysaa tayada nolosha waxayna yareyneysaa dibbiro, matag, calool xanuun, iyo tirada dhaqdhaqaaqa caloosha dadka qaba shuban-biyoodka ugu badan ee IBS. Cilmi-baaris kale oo caafimaad ayaa muujineysa in qaadashada shey isku-dhafan oo gaar ah (Colinox, DMG Italia SRL) oo ay ku jiraan Bacillus coagulans iyo simethicone saddex jeer saddex jeer maalin kasta muddo 4 toddobaad ah ay hagaajinayso buurbuurnaanta iyo raaxo-darrada dadka qaba IBS.

Cadeymo aan ku filneyn in lagu qiimeeyo wax ku oolnimada ...

• Nabar ku dhaca beerka (cirrhosis). Dadka qaba beerka cirrhosis-ka waxay u badan tahay inuu ku dhaco infekshin loo yaqaan 'spontaneous bacterial peritonitis', ama 'SBP'. Daraasad hore waxay muujineysaa in qaadashada isku-darka probiotic oo ay ku jiraan Bacillus coagulans iyo bakteeriyada kale seddex jeer maalintii, oo ay weheliso daroogada norfloxacin, ma yareyneyso halista qofka ee ah inuu ku dhaco SBP.
• Calool fadhiga. Daraasad hore waxay muujisay qaadashada Bacillus coagulans laba jeer maalintii 4 usbuuc waxay hagaajin kartaa xanuunka caloosha iyo raaxo la'aanta dadka u muuqda calool istaagga.
• Shuban. Cilmibaaristii ugu horreysay ee carruurta jirta 6-24 bilood ee qaba shubanku waxay muujineysaa in qaadashada Bacillus coagulans illaa 5 maalmood aysan yareynaynin shubanka. Laakiin qaadashada Bacillus coagulans waxay umuuqataa inay wanaajineyso shubanka iyo calool xanuunka dadka waaweyn.
• Shuban uu sababo rotavirus. Daraasad hore oo lagu sameeyay ilmaha dhasha ah waxay muujineysaa in qaadashada Bacillus coagulans maalin kasta hal sano ay yareyneyso halista canugga inuu ku dhaco shuban rotavirus.
• Gaas (gaaska). Caddaynta hore ee dadka gaaska leh markay wax cunayaan ka dib waxay muujineysaa in qaadashada isku dhaf ah oo isku dhafan oo ay ku jiraan Bacillus coagulans iyo isku dar ah enzymes maalin kasta muddo 4 toddobaad ah aysan hagaajinayn buurnaanta ama gaaska.
• Dheefshiidka (dyspepsia). Daraasad hore waxay muujisay qaadashada Bacillus coagulans maalin kasta 8 toddobaad inay yareyn karto astaamaha daan daansiga, calool xanuun, iyo dhadhanka dhanaan. Cilmi baaris kale waxay muujineysaa in Bacillus coagulans-ka la qaato laba jeer maalintii 4 usbuuc uu yareeyo xanuunka caloosha iyo dibbiro.
• Kordhinta xad dhaafka ah ee bakteeriyada mindhicirada yar. Caddaynta hore waxay muujineysaa in la isticmaalo badeecad probiotic gaar ah (Lactol, Bioplus Life Sciences Pvt. Ltd.) oo ay ku jiraan Bacillus coagulans iyo fructo-oligosaccharides maalin kasta 15 maalmood bil kasta muddo 6 bilood ah ayaa si yar u yareyn kara xanuunka caloosha iyo gaaska dadka qaba bakteeriyada waxyeelada leh. xiidmaha.
• Rheumatoid arthritis (RA). Daraasad hore waxay muujisay qaadashada Bacillus coagulans maalin kasta muddo 60 maalmood ah marka lagu daro daaweynta caadiga ah waxay yareyn kartaa xanuunka, laakiin ma yareynayso tirada kalagoysyada xanuunka leh ama barara ee dadka qaba RA. Bacillus coagulans sidoo kale ma hagaajiso awoodda waxqabad ee nolol maalmeedka dadka qaba RA.
• Cudur xiidmaha oo halis ah oo ku dhaca dhallaanka dhiciska ah (necrotizing enterocolitis ama NEC). Carruurta ku dhasha goor hore ama miisaankoodu aad u hooseeyo waxay halis weyn ugu jiraan inuu ku dhaco infekshin daran oo ku dhaca mindhicirada oo loo yaqaan necrotizing enterocolitis. Cilmibaaris hore oo carruurtan la sameeyay waxay muujineysaa in qaadashada Bacillus coagulans maalin kasta illaa iyo inta laga saarayo isbitaalka aysan ka hortegeynin neero-baroorayaasha enterocolitis ama geeri. Si kastaba ha noqotee, qaadashada Bacillus coagulans waxay kordhisaa tirada carruurta ee awooda inay u dulqaataan cuntada.
• Ku abuur baruurta beerka dadka cabba wax yar ama aan khamri lahayn (cudurka beerka dufanka leh ee aan dufan lahayn ama NAFLD).
• Kahortaga kansarka.
• Infekshinka marinka caloosha iyo bakteeriyada loo yaqaan Clostridium wuya.
• Dhibaatooyinka dheefshiidka.
• Caabuq ku dhaca mareenka dheef-shiidka oo u horseedi kara nabarro (Helicobacter pylori ama H. ​​pylori).
• Xoojinta nidaamka difaaca jirka.
• Barar muddo dheer ah (caabuq) ku dhaca habka dheef-shiidka (Cudurka Mindhicirka Caabuqa ama IBD).
• Caabuqa marinnada hawada.
• Xaaladaha kale.

Cadeymo dheeraad ah ayaa loo baahan yahay si loogu qiimeeyo Bacillus coagulans adeegyadan. Ma jiro macluumaad ku filan oo lagu ogaanayo sida Bacillus coagulans ay ugu shaqeyn karto ujeedooyin caafimaad. Cilmi baarista qaar waxay muujineysaa in Bacillus coagulans ay kordhin karto shaqada nidaamka difaaca jirka ayna yareyneyso bakteeriyada waxyeellada leh.

Markii afka lagaa qaado: Bacillus coagulans waa BADBAADO KU SAABSAN marka afka lagaa qaado. Cilmi baaris ayaa muujisay in Bacillus coagulans oo ku jira qiyaasta 2 bilyan oo unugyo sameys ah (CFUs) maalin kasta si badbaado leh loo isticmaali karo ilaa 3 bilood. Qiyaasaha hoose ee Bacillus coagulans ilaa 100 milyan CFUs maalin kasta si badbaado leh ayaa loo isticmaali karaa ilaa 1 sano.

Taxaddarrada gaarka ah & digniinta:

Uurka iyo nuujinta: Ma jiro macluumaad ku filan oo la isku halleyn karo oo ku saabsan badbaadada qaadashada Bacillus coagulans haddii aad uur leedahay ama aad naas nuujiso. Joog dhinaca aaminka ah iskana ilaali isticmaalka.

Caruurta: Bacillus coagulans waa BADBAADO KU SAABSAN markii afka lagaa qaado dhallaanka iyo carruurta. Daraasad la sameeyay qaarkood ayaa muujisay in Bacillus coagulans ilaa 100 milyan oo unugyo sameys ah (CFUs) maalin kasta ay si badbaado leh u isticmaali karaan dhallaanka ilaa hal sano.

Dhexdhexaad

Ka taxaddar isku-dhafkan.

Dawooyinka antibiyootikada

Antibiyootikada waxaa loo isticmaalaa in lagu yareeyo bakteeriyada waxyeellada leh ee jirka ku jirta. Antibiyootikada ayaa sidoo kale yareyn karta bakteeriyada kale ee jirka ku jirta. Qaadashada antibiyootikada oo ay weheliso Bacillus coagulans waxay yareyn kartaa faa'iidooyinka ay yeelan karto Bacillus coagulans. Si looga fogaado isdhexgalkaan suurtogalka ah, qaado alaabada Bacillus coagulans ugu yaraan 2 saacadood kahor ama kadib antibiotics.

Daawooyinka yareeya nidaamka difaaca jirka (Immunosuppressants)

Bacillus coagulans waxay kordhin kartaa waxqabadka nidaamka difaaca jirka. Qaadashada Bacillus coagulans oo ay weheliso daawooyinka yareeya waxqabadka nidaamka difaaca jirka ayaa hoos u dhigi kara waxtarka daawooyinkan.
Daawooyinka qaar ee yareeya dhaqdhaqaaqa nidaamka difaaca jirka waxaa ka mid ah azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (tacrolimus) Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), iyo kuwa kale.

Ma jiraan is-dhexgal la yaqaan oo leh geedo iyo waxyaabo dheeri ah.

Ma jiraan wax la yaqaan oo la falgala cunnooyinka.

Qiyaasaha soo socda ayaa lagu bartay cilmi baarista sayniska:

DADKA WAAWEYN

Afka:

• Cillada muddada-dheer ee mindhicirada waaweyn ee sababa calool xanuun (cillad-darrada mindhicirka xanaaqa ama IBS): Bacillus coagulans (Lactospore, Sabinsa Corporation) 2 bilyan oo gumaysi dhisme ah (CFUs) maalin kasta 90 maalmood. Bacillus coagulans (GanedenBC30, Ganeden Biotech Inc.) 300 milyan ilaa 2 bilyan CFUs maalin kasta 8 toddobaad. Sidoo kale, badeecad isku dhafan oo la isku daray (Colinox, DMG Italia SRL) oo ay ku jiraan Bacillus coagulans iyo simethicone ayaa la isticmaalay ka dib cunno kasta seddex jeer maalintii 4 toddobaad.

B. Coagulans, Bacillus Bacteria, Bacillus Probiotics, Bacteus Bacilles, Bactéries à Gram Positif Sporogènes, Bactérie Gram Positive en Forme de Bâtonnet, Gram Positive Spore-Forming Rod, L. Sporogenes, Lactobacillus Sporogenes, Lactobacillus, Xakamaynta Bacorus, Samaynta Lactobacillus.

Si aad wax badan uga ogaato sida maqaalkan loo qoray, fadlan eeg Daawooyinka Dabiiciga ah ee Xogta Dhamaystiran habka.

1. Kumar VV, Sudha KM, Bennur S, Dhanasekar KR. Daraasad la filayo, oo la kala sooco, calaamadeysan oo furan, xakameyn ah xakamaynta placebo ee Bacillus coagulans GBI-30,6086 oo leh enzymes dheef-shiid kiimikaad ah oo lagu hagaajinayo calool-xumada dadka da'da ah. J Daryeelka Caafimaadka Aasaasiga ah ee Qoyska. 2020; 9: 1108-1112. Eeg aragti
2. Chang CW, Chen MJ, Shih SC, iyo al. Bacillus coagulans (PROBACI) oo lagu daaweynayo calool-fadhiga caloosha ku badan ee shaqeynaya. Daawada (Baltimore). 2020; 99: e20098. Eeg aragti
3. Soman RJ, Swamy MV. Daraasad mustaqbalka ah, la kala soocay, laba-indhoole ah, xakameyn placebo ah, daraasad kooxeed si loo qiimeeyo waxtarka iyo badbaadada SNZ TriBac, oo ah seddex nooc oo isku-dhafan Bacillus probiotic oo loogu talagalay raaxo-darrada caloosha iyo mindhicirka. Int J Colorectal Dis. 2019; 34: 1971-1978. Eeg aragti
4. Abhari K, Saadati S, Yari Z, et al. Saameynta Bacillus coagulans kaabista bukaanada qaba cudurka beerka dufanka leh ee aan khamriga lahayn: Isugeyn, xakameyn xakameyn, tijaabo caafimaad. Clin Nutr ESPEN. 2020; 39: 53-60. Eeg aragti
5. Maity C, Gupta AK. Daraasad caafimaad oo la filayo, dhex-dhexaad ah, kala-sooc ah, laba-indhoole ah, oo lagu xakameynayo placebo ah si loo qiimeeyo waxtarka iyo badbaadada Bacillus coagulans LBSC ee daaweynta shubanka ba'an ee leh raaxo-darrada caloosha. Eur J Clin Pharmacol. 2019; 75: 21-31. Eeg aragti
6. Hun L. Bacillus coagulans wuxuu si weyn u wanaajiyay xanuunka caloosha iyo burooyinka bukaanka qaba IBS. Dib-u-dhigis Med 2009; 121: 119-24. Eeg aragti
7. Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation of antiretroviral drug-suppress chronic HIV-1 insis in probiotic afka laba-indho-indho-indheyn tijaabo ah. Dib-u-Celinta AIDS-ka ee Res 2014; 30: 988-95. Eeg aragti
8. Dutta P, Mitra U, Dutta S, iyo al. Tijaabinta tijaabada caafimaad ee la xakameynayo ee laktobacillus sporogenes (Bacillus coagulans), oo loo adeegsado habdhaqanka daaweynta caafimaadka, shuban biyoodka ba'an ee carruurta. Caafimaadka Trop Med Int 2011; 16: 555-61. Eeg aragti
9. Endres JR, Clewell A, Jade KA, iyo al. Qiimaynta amniga ee diyaarsanaanta lahaanshaha ee probiotic sheeko, Bacillus coagulans, oo ah qayb ka kooban cuntada. Cuntada Chem Toxicol 2009; 47: 1231-8. Eeg aragti
10. Kalman DS, Schwartz HI, Alvarez P, iyo al. Tijaabin, kala-soocid, laba-indho-indho-indho-indho-indheyn ah, xakameyn-kooxeed oo laba-geesood ah oo tijaabo ah si loo qiimeeyo saameynta alaabada Bacillus coagulans-ku saleysan calaamadaha gaaska xiidmaha BMC Gastroenterol 2009; 9: 85. Eeg aragti
11. Dolin BJ. Saameynta lahaanshaha lahaanshaha Bacillus coagulans ee astaamaha cudurka shuban-biyoodka calool xanuunka badan. Hababka loo raadsado Ex Clin Pharmacol 2009; 31: 655-9. Eeg aragti
12. Mandel DR, Eichas K, Holmes J. Bacillus coagulans: waa daaweyn wax ku ool ah oo wax ku ool ah oo lagu yareynayo astaamaha xanuunka 'rheumatoid arthritis' sida ku xusan tijaabinta, tijaabada la xakameeyey. BMC Iskudarka Kale ee Med 2010; 10: 1. Eeg aragti
13. Sari FN, Dizdar EA, Oguz S, iyo al. Daaweynta afka: Lactobacillus sporogenes ee kahortagga necrotizing enterocolitis ee dhallaanka miisaanka yar ee dhalashada: tijaabin la kala sooco, la xakameeyo. Eur J Clin Nutr 2011; 65: 434-9. Eeg aragti
14. Riazi S, Wirawan RE, Badmaev V, Chikindas ML. Astaamaynta lactosporin, borotiinka cusub ee antimicrobial ee ay soo saartay Bacillus coagulans ATCC 7050. J Appl Microbiol 2009; 106: 1370-7. Eeg aragti
15. Pande C, Kumar A, Sarin SK. Ku darista daawada probiotics-ka ee loo yaqaan 'norfloxacin' ma hagaajinayso waxtarka ka hortagga bakteeriyada iska hor imaadku ku yimaad: is-tijaabinta kontoroolka la xakameeyey ee laba-indhoole ah. Eur J Gastroenterol Hepatol 2012; 24: 831-9. Eeg aragti
16. Majeed M, Nagabhushanam K, Natarajan S, iyo al. Bacillus coagulans MTCC 5856 dheeri ah ee maaraynta cudurka shubanka ee cudurada caloosha xanaaqa badan: daraasad caafimaad oo tijaabo ah oo tijaabo ah oo lagu tijaabiyo placebo. Nutr J 2016; 15: 21. Eeg aragti
17. Chandra RK. Saamaynta Lactobacillus ee ku saabsan dhacdooyinka iyo darnaanta shuban-biyoodka ba'an ee rotafayruus ee dhallaanka. Daraasad laba-indhoole ah oo la xakameynayo oo la xakameynayo. Nutr Qaraarka 2002; 22: 65-9.
18. De Vecchi E, Drago L. Lactobacillus sporogenes ama Bacillus coagulans: aqoonsi khaldan ama qaldan? Int J Probiotics Prebiotics 2006; 1: 3-10.
19. Jurenka JS. Bacillus coagulans: Monograph. Beddelka 'Med' Rev 2012; 17: 76-81. Eeg aragti
20. Urgesi R, Casale C, Pistelli R, iyo al. Tijaabin laba-indho-indho-indho-indhayn ah oo la xakameeyey oo ku saabsan waxtarka iyo amniga isku-xirnaanta simethicone iyo Bacillus coagulans (Colinox) ee bukaannada qaba cilladda mindhicirka xanaaqa. Eur Rev Med Pharmacol Sci 2014; 18: 1344-53. Eeg aragti
21. Khalighi AR, Khalighi MR, Behdani R, iyo al. Qiimeynta waxtarka probiotic ee daaweynta bukaanka qaba bakteeriyada yar yar ee xiidmaha (SIBO) - daraasad tijaabo ah. Hindida J Med Res. 2014 N ov; 140: 604-8. Eeg aragti
22. Czaczyk K, Tojanowska K, Mueller A. Waxqabadka antifungal ee Bacillus coagulans ee ka dhanka ah Fusarium sp. Acta Microbiol Pol 2002; 51: 275-83. Eeg aragti
23. Donskey CJ, Hoyen CK, Das SM, iyo al. Saamaynta afka Bacillus coagulans ee ku saabsan cufnaanta enterococci u adkaysata vancomycin ee saxarada jiirka la gumaysto. Lett Appl Microbiol 2001; 33: 84-8. Eeg aragti
24. Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, oo hoosaadyada bakteeriyada u eg ee ka hortagga ah ee ay soo saarto Bacillus coagulans I4. J Appl Microbiol 1998; 85: 42-50. Eeg aragti
25. Probiotics-ka loogu talagalay shubanka la xiriira antibiyootikada. Warqadda Farmashiistaha / Qoraalka Waraaqaha 2000; 16: 160103.
26. Duc LH, Hong HA, Barbosa TM, iyo al. Astaamaha lagu garto daawooyinka loo yaqaan 'Bacillus probiotics' ee loo heli karo isticmaalka aadanaha. Appl Environ Microbiol 2004; 70: 2161-71. Eeg aragti
27. Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Ka hortagga isku dhejinta bilowga ah ee uropathogenic Enterococcus faecalis by biosurfactants oo ka yimaada go'doominta Lactobacillus. Appl Environ Microbiol 1996; 62: 1958-63. Eeg aragti
28. McGroarty JA. Isticmaalka probiotic ee lactobacilli ee marinka urogenital-ka dumarka. FEMS Immunol Med Microbiol 1993; 6: 251-64. Eeg aragti
29. Reid G, Bruce AW, Cook RL, iyo al. Saameyn ku yeelashada dhirta urogenital ee daaweynta antibiyootikada ee cudurka infekshinka kaadi mareenka. Scand J Infekshanka Dis 1990; 22: 43-7. Eeg aragti

Markii ugu dambeysay ee dib loo eegay - 12/04/2020